LisaMMcGregorMD

Pediatric Hematology & Oncology • Hershey, PA

Pediatric Solid Tumor Oncology

Professor of Pediatrics, Penn State College of Medicine

Join to view full profile

Dr. McGregor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. McGregor's full profile

Already have an account?

Office
500 University Dr
Hershey, PA 17033
Phone+1 717-531-6012

Fax+1 717-531-4789
Is this information wrong?

Summary

Dr. Lisa McGregor is a pediatric hematologist/oncologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 19 years. She specializes in pediatric solid tumor oncology.

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2001 - 2004
Duke University HospitalResidency, Pediatrics, 1998 - 2001
Johns Hopkins University School of MedicineClass of 1998

Certifications & Licensure

PA State Medical License 2012 - 2024
TN State Medical License 2004 - 2012
NC State Medical License 1998 - 2001
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2004 Nov 01
Terminated
Phase 1
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors Start of enrollment: 2005 Sep 01
Completed
Phase 1
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
Recruiting
A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors Start of enrollment: 2008 Jul 01
Completed
Phase 1
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Completed
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Completed
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Chronic pain in children and adolescents diagnosed with cancer: the challenge of mitigating the pain and the potential of integrating exercise into pain management.
Maxime Caru, Nicole M Alberts, Michelle C Freeman, Smita C Dandekar, Pooja Rao, Daniel J McKeone, Valerie I Brown, Lisa M McGregor, Kathryn H Schmitz> ;Supportive Care in Cancer. 2023 Mar 23
13 citations
A scoping review to map the evidence of physical activity interventions in post-treatment adolescent and young adult cancer survivors.
Maxime Caru, Ariane Levesque, Pooja Rao, Smita Dandekar, Christopher Terry, Valerie Brown, Lisa McGregor, Kathryn Schmitz> ;Critical Reviews in Oncology/hematology. 2022 Mar 1
9 citations
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors
Victor M. Santana, Natasha Sahr, Ruth G. Tatevossian, Sujuan Jia, Olivia Campagne, April Sykes, Clinton F. Stewart, Wayne L. Furman, Lisa M. McGregor> ;Cancer. 2020 Apr 15
2 citations
Attendance at National Cancer Institute and Children's Oncology Group Facilities for Children, Adolescents, and Young Adults with Cancer in Pennsylvania: A Population-...
Pooja Rao, Joel E. Segel, Lisa M. McGregor, Eugene J. Lengerich, Joseph J. Drabick, Barbara A. Miller> ;Journal of Adolescent and Young Adult Oncology. 2020 Feb 10
3 citations
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.
Catherine G. Lam, Wayne L. Furman, Chong Wang, Sheri L. Spunt, Jianrong Wu, Percy Ivy, Victor M. Santana, Lisa M. McGregor> ;Journal of Pediatric Hematology/oncology. 2015 Jan 1
17 citations
Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.
Sara M. Federico, Heather B. Allewelt, Sheri L. Spunt, Melissa M. Hudson, Jianrong Wu, Catherine A. Billups, Jesse J. Jenkins, Victor M. Santana, Wayne L. Furman, Lisa...> ;Journal of Pediatric Hematology/oncology. 2015 Jan 1
20 citations
Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
Rachel C. Brennan, Wayne L. Furman, Shenghua Mao, Jianrong Wu, David C. Turner, Clinton F. Stewart, Victor M. Santana, Lisa M. McGregor> ;Cancer Chemotherapy and Pharmacology. 2014 Sep 26
106 citations
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
Fariba Navid, Paul M. Sondel, Raymond C. Barfield, Barry L. Shulkin, Robert A. Kaufman, Jim A. Allay, Jacek Gan, Paul R. Hutson, Songwon Seo, Kyung Mann Kim, Jacob Gol...> ;Journal of Clinical Oncology. 2014 May 10
20 citations
Repeat nephron-sparing surgery for children with bilateral Wilms tumor.
Kathleen Kieran, Mark A. Williams, Lisa M. McGregor, Jeffrey S. Dome, Matthew J. Krasin, Andrew M. Davidoff> ;Journal of Pediatric Surgery. 2014 Jan 1
23 citations
Margin status and tumor recurrence after nephron-sparing surgery for bilateral Wilms tumor ☆
Kathleen Kieran, Mark A. Williams, Jeffrey S. Dome, Lisa M. McGregor, Matthew J. Krasin, Andrew M. Davidoff> ;Journal of Pediatric Surgery. 2013 Jul 1
27 citations
Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent
Emilia M. Pinto, Christopher L. Morton, Carlos Rodriguez-Galindo, Lisa M. McGregor, Andrew M. Davidoff, Kimberly S Mercer, Larisa V. Debelenko, Catherine A. Billups, R...> ;Clinical Cancer Research. 2013 Apr 1
6 citations
Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model.
Joseph E. Hartwich, W. Shannon Orr, Catherine Y.C. Ng, Yunyu Spence, Jillian M. McLaughlin, Wayne L. Furman, Lisa M. McGregor, Andrew M. Davidoff> ;Journal of Pediatric Surgery. 2013 Jan 1
60 citations
Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors
Fariba Navid, Sharyn D. Baker, M. Beth McCarville, Clinton F. Stewart, Catherine A. Billups, Jianrong Wu, Andrew M. Davidoff, Sheri L. Spunt, Wayne L. Furman, Lisa M. ...> ;Clinical Cancer Research. 2013 Jan 1
29 citations
Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma†
Atmaram S. Pai Panandiker, Chris Beltran, Catherine A. Billups, Lisa M. McGregor, Wayne L. Furman, Andrew M. Davidoff> ;Pediatric Blood & Cancer. 2013 May 1
27 citations
Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors
Lisa M. McGregor, Clinton F. Stewart, Kristine R. Crews, Michael Tagen, Amy Wozniak, Jianrong Wu, M. Beth McCarville, Fariba Navid, Victor M. Santana, Peter J. Houghto...> ;Pediatric Blood & Cancer. 2012 Mar 1
19 citations
Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas
Matthew J. Krasin, Kristin M. Wiese, Sheri L. Spunt, Chia Ho Hua, Najat C. Daw, Fariba Navid, Andrew M. Davidoff, Lisa M. McGregor, Thomas E. Merchant, Larry E. Kun, L...> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Jan 1
32 citations
A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma.
Larisa V. Debelenko, Lisa M. McGregor, Bangalore R. Shivakumar, Howard D. Dorfman, Susana C. Raimondi> ;Genes, Chromosomes & Cancer. 2011 Dec 1
6 citations
Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis.
Israel Fernandez-Pineda, Armita Bahrami, James F. Green, Lisa M. McGregor, Andrew M. Davidoff, John A. Sandoval> ;Journal of Pediatric Surgery. 2011 Oct 1
23 citations
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma
Wayne L. Furman, Lisa M. McGregor, M. Beth McCarville, Mihaela Onciu, Andrew M. Davidoff, Sandy Kovach, Dana Hawkins, Valerie McPherson, Peter J. Houghton, Catherine A...> ;Investigational New Drugs. 2012 Aug 1
10 citations
Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor.
Emilia M. Pinto, Raul C. Ribeiro, Gad B. Kletter, John P. Lawrence, Jesse J. Jenkins, Jinling Wang, Sheila A. Shurtleff, Lisa M. McGregor, Richard W. Kriwacki, Gerard ...> ;Familial Cancer. 2011 Mar 1
12 citations
Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib
Trevor McKibbin, Wei Zhao, Michael Tagen, Najat C. Daw, Wayne L. Furman, Lisa M. McGregor, J. Russell Geyer, Jeffrey Warren Allen, Clinton F. Stewart> ;European Journal of Cancer. 2010 Jul 1
1 citations
Zygomycosis originating from an odontogenic infection in a pediatric oncology patient
Elisabeth E. Adderson, Christopher Rowland, Lisa M. McGregor, Victor M. Santana> ;Diagnostic Microbiology and Infectious Disease. 2010 May 1
24 citations
Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.
Jared R. Robbins, Matthew J. Krasin, Atmaram S. Pai Panandiker, Amy Watkins, Jianrong Wu, Victor M. Santana, Wayne L. Furman, Andrew M. Davidoff, Lisa M. McGregor> ;Journal of Pediatric Surgery. 2010 Apr 1
41 citations
Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors
Wayne L. Furman, Fariba Navid, Najat C. Daw, M. Beth McCarville, Lisa M. McGregor, Sheri L. Spunt, Carlos Rodriguez-Galindo, John C. Panetta, Kristine R. Crews, Jianro...> ;Journal of Clinical Oncology. 2009 Sep 20
22 citations
Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma.
Atmaram S. Pai Panandiker, Lisa M. McGregor, Matthew J. Krasin, Shengjie Wu, Xiaoping Xiong, Thomas E. Merchant> ;International Journal of Radiation Oncology, Biology, Physics. 2007 Nov 1
Join now to see all